Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study
Status:
Recruiting
Trial end date:
2026-08-31
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind controlled trial of choline supplementation in children
with Fetal Alcohol Spectrum Disorders (FASD). The study is comparing two administration
durations (3 months vs. 6 months) of choline. The primary outcome measures are cognitive
measures.
Phase:
Phase 2
Details
Lead Sponsor:
Jeff Wozniak
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)